Trailing-twelve-month (TTM) revenue is $3.64 Billion with a year-over-year growth of (0.18%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-27 | $1,058,503,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-03 |
| Q3 FY2026Period ended 2025-12-27 | $992,959,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-28 |
| Q4 FY2026Period ended 2026-03-28 | $808,277,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q1 FY2027Period ended 2026-06-27 | $784,795,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $3,644,534,000 |
Current P/S: $10,072,260,072 market capitalization ÷ $3,644,534,000 TTM revenue = 2.76x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:00.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-27): $784.79M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T20:00:57.864Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-04-03 · USD | FY20222022-04-02 · USD | FY20232023-04-01 · USD | FY20242024-03-30 · USD | FY20252025-03-29 · USD | FY20262026-03-28 · USD |
|---|---|---|---|---|---|---|
| ACG | N/A | N/A | $2.4B | $2.8B | $2.6B | $2.6B |
| CSG | N/A | N/A | $474M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-04-03 · USD | FY20222022-04-02 · USD | FY20232023-04-01 · USD | FY20242024-03-30 · USD | FY20252025-03-29 · USD | FY20262026-03-28 · USD |
|---|---|---|---|---|---|---|
| CHINA | $1.6B | $1.5B | $741M | $727M | $620M | $475M |
| Europe | $193M | $252M | $202M | $88M |
$3.64B
$3.64 Billion
(0.18%)
vs. $3.65B a year ago (TTM)
(1.83%)
5 Year compound annual growth rate
1 Year
(0.18%)
3 Year
+0.64%
5 Year
(1.83%)
10 Year
+3.31%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $3.68B | ($40.45M) | (1.09%) |
| 2025 | $3.72B | ($50.53M) | (1.34%) |
| 2024 | $3.77B | +$200.11M | +5.61% |
| 2023 | $3.57B | ($1.08B) | (23.17%) |
| 2022 | $4.65B | +$630.41M | +15.70% |
| 2021 |
TTM Growth
(0.18%)
3-Year CAGR
+0.64%
5-Year CAGR
(1.83%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-02T20:00:57.864Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $473M |
| $422M |
| HPA | N/A | N/A | $727M | $573M | $637M | $706M |
|---|
| Infrastructure and Defense Products | $1.2B | $1.1B | N/A | N/A | N/A | N/A |
|---|
| Mobile Products | $2.9B | $3.5B | N/A | N/A | N/A | N/A |
|---|
| $98M |
| Other Asia | $364M | $621M | $499M | $518M | $444M | $432M |
|---|
| TAIWAN, PROVINCE OF CHINA | $249M | $346M | $309M | $261M | $341M | $358M |
|---|
| UNITED STATES | $1.6B | $1.9B | $1.8B | $2.2B | $2.2B | $2.3B |
|---|
| $4.02B |
| +$776.17M |
| +23.96% |
| 2020 | $3.24B | +$148.82M | +4.82% |
| 2019 | $3.09B | +$116.79M | +3.93% |
| 2018 | $2.97B | ($59.04M) | (1.95%) |
| 2017 | $3.03B | +$421.85M | +16.16% |
